subcutaneous Low Molecular Weight Heparin: Clinical Trials

1 trial of subcutaneous Low Molecular Weight Heparin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow subcutaneous Low Molecular Weight Heparin: new trials by email Literature Review of subcutaneous Low Molecular Weight Heparin trials Research Report on subcutaneous Low Molecular Weight Heparin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular Weight Heparin - Cirrhosis, Splenectomy
Not applicableCompletedNorthern Jiangsu People's Hospital402022-04-012023-12-21

Conditions studied

Fibrosis (1)  ·  Hypertension, Portal (1)  ·  Venous Thrombosis (1)

Sponsors

Northern Jiangsu People's Hospital (1)

Countries

China (1)

Top investigators

Ping Chen, MD (1)